carbogen has been researched along with Sarcoma, Epithelioid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M; Masunaga, S; Ono, K | 1 |
| Horsman, MR; Knühmann, K; Sack, H; Stüben, G; Stuschke, M | 1 |
| Brauers, G; Chaplin, DJ; Collingridge, DR; Edwards, B; Hill, SA; Honess, DJ; Powell, NA | 1 |
3 other study(ies) available for carbogen and Sarcoma, Epithelioid
| Article | Year |
|---|---|
The detection and modification of the hypoxic fraction in quiescent cell populations in murine solid tumours.
Topics: Animals; Carbon Dioxide; Carcinoma, Squamous Cell; Cell Survival; Female; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Niacinamide; Oxygen; Radiation Tolerance; Radiation-Sensitizing Agents; Sarcoma; Tumor Cells, Cultured | 1993 |
The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies.
Topics: Administration, Inhalation; Animals; Carbon Dioxide; Cell Hypoxia; Drug Combinations; Glioblastoma; Humans; Injections, Intraperitoneal; Mice; Mice, Nude; Neoplasm Transplantation; Neurofibrosarcoma; Niacinamide; Oxygen; Oxygen Consumption; Radiation-Sensitizing Agents; Radiotherapy Dosage; Sarcoma; Sarcoma, Experimental; Skin Neoplasms; Transplantation, Heterologous | 1998 |
Preclinical evaluation of the novel hypoxic marker 99mTc-HL91 (Prognox) in murine and xenograft systems in vivo.
Topics: Adenocarcinoma; Animals; Carbon Dioxide; Carcinoma; Cell Hypoxia; Colonic Neoplasms; Contrast Media; Humans; Lung Neoplasms; Mice; Mice, Inbred CBA; Mice, SCID; Niacinamide; Organotechnetium Compounds; Oximes; Oxygen; Radiopharmaceuticals; Sarcoma | 1998 |